
Validea's analysis, applying Warren Buffett's 'Patient Investor model,' rates ASML HOLDING NV (ADR) (ASML) at 86%, signaling interest in the large-cap semiconductor stock. This high rating stems from ASML's strong fundamentals, including predictable profitability, low debt, and robust free cash flow, passing most key criteria for long-term value, despite failing the 'Initial Rate of Return' test.
ASML Holding NV (ASML) scores a high 86% on Validea's Patient Investor model, which is based on Warren Buffett's investment strategy, indicating significant interest in the large-cap semiconductor firm. This rating is underpinned by the company's strong performance across nearly all fundamental criteria, including passing tests for earnings predictability, low debt service, high return on equity, and robust free cash flow. The analysis further highlights effective capital management, as ASML passed criteria for its use of retained earnings and share repurchases. The only point of failure within this framework is the 'Initial Rate of Return' test, which suggests that while the company's underlying quality is exceptional, its current valuation may not meet the strict criteria for an immediate, high-return investment from a value perspective. The overall sentiment is strongly positive, with a ticker-specific score of 0.85, reinforcing the bullish view on the company's fundamental health and market position.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment